A University of Colorado professor won the 2024 Alton Ochsner Award for his work on disease risk factors for idiopathic ...
In addition to pulmonary fibrosis, columnist Ann Reynoso is now also dealing with sleep apnea — both of which affect her ...
A Phase 2b clinical trial is testing the safety and efficacy of AP01, inhaled pirfenidone, in people with progressive PF.
Living with IPF has brought many emotional ups and downs for columnist Sam Kirton, and recent events have caused him to hit ...
After his brother's diagnosis, columnist Sam Kirton has new questions about the nature of familial idiopathic pulmonary fibrosis.
Immune cell profiling revealed differences between two types of pulmonary fibrosis that could guide the development of new ...